DEFERASIROX — all Canadian products
46 DINs
40 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DEFERASIROX, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02564939 | ALEMBIC-DEFERASIROX (TYPE J) | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | Oral | DEFERASIROX 360 MG | Approved | |
| 02461552 | APO-DEFERASIROX | APOTEX INC | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Marketed | |
| 02461544 | APO-DEFERASIROX | APOTEX INC | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Marketed | |
| 02461560 | APO-DEFERASIROX | APOTEX INC | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Marketed | |
| 02485273 | APO-DEFERASIROX (TYPE J) | APOTEX INC | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02485265 | APO-DEFERASIROX (TYPE J) | APOTEX INC | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02485281 | APO-DEFERASIROX (TYPE J) | APOTEX INC | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02527774 | AURO-DEFERASIROX (TYPE J) | AURO PHARMA INC | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02527790 | AURO-DEFERASIROX (TYPE J) | AURO PHARMA INC | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02527782 | AURO-DEFERASIROX (TYPE J) | AURO PHARMA INC | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02527359 | DEFERASIROX (TYPE J) | JUBILANT GENERICS LIMITED | Tablet | Oral | DEFERASIROX 180 MG | Approved | |
| 02527367 | DEFERASIROX (TYPE J) | JUBILANT GENERICS LIMITED | Tablet | Oral | DEFERASIROX 360 MG | Approved | |
| 02527340 | DEFERASIROX (TYPE J) | JUBILANT GENERICS LIMITED | Tablet | Oral | DEFERASIROX 90 MG | Approved | |
| 02287420 | EXJADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Marketed | |
| 02287439 | EXJADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Marketed | |
| 02287447 | EXJADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Marketed | |
| 02452219 | JADENU | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02452227 | JADENU | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02452235 | JADENU | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02549859 | JAMP DEFERASIROX (TYPE J) | JAMP PHARMA CORPORATION | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02549840 | JAMP DEFERASIROX (TYPE J) | JAMP PHARMA CORPORATION | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02549832 | JAMP DEFERASIROX (TYPE J) | JAMP PHARMA CORPORATION | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02474336 | PMS-DEFERASIROX | PHARMASCIENCE INC | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Marketed | |
| 02474344 | PMS-DEFERASIROX | PHARMASCIENCE INC | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Marketed | |
| 02474328 | PMS-DEFERASIROX | PHARMASCIENCE INC | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Marketed | |
| 02528304 | PMS-DEFERASIROX (TYPE J) | PHARMASCIENCE INC | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02528290 | PMS-DEFERASIROX (TYPE J) | PHARMASCIENCE INC | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02528312 | PMS-DEFERASIROX (TYPE J) | PHARMASCIENCE INC | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02464462 | SANDOZ DEFERASIROX | SANDOZ CANADA INCORPORATED | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Marketed | |
| 02464470 | SANDOZ DEFERASIROX | SANDOZ CANADA INCORPORATED | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Marketed | |
| 02464454 | SANDOZ DEFERASIROX | SANDOZ CANADA INCORPORATED | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Marketed | |
| 02489910 | SANDOZ DEFERASIROX (TYPE J) | SANDOZ CANADA INCORPORATED | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02489899 | SANDOZ DEFERASIROX (TYPE J) | SANDOZ CANADA INCORPORATED | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02489902 | SANDOZ DEFERASIROX (TYPE J) | SANDOZ CANADA INCORPORATED | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02463520 | TARO-DEFERASIROX | TARO PHARMACEUTICALS INC | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Marketed | |
| 02463539 | TARO-DEFERASIROX | TARO PHARMACEUTICALS INC | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Marketed | |
| 02463547 | TARO-DEFERASIROX | TARO PHARMACEUTICALS INC | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Marketed | |
| 02507331 | TARO-DEFERASIROX (TYPE J) | TARO PHARMACEUTICALS INC | Tablet | Oral | DEFERASIROX 360 MG | Marketed | |
| 02507323 | TARO-DEFERASIROX (TYPE J) | TARO PHARMACEUTICALS INC | Tablet | Oral | DEFERASIROX 180 MG | Marketed | |
| 02507315 | TARO-DEFERASIROX (TYPE J) | TARO PHARMACEUTICALS INC | Tablet | Oral | DEFERASIROX 90 MG | Marketed | |
| 02407973 | TEVA-DEFERASIROX | TEVA CANADA LIMITED | Tablet For Suspension | Oral | DEFERASIROX 500 MG | Cancelled Post Market | |
| 02407957 | TEVA-DEFERASIROX | TEVA CANADA LIMITED | Tablet For Suspension | Oral | DEFERASIROX 125 MG | Cancelled Post Market | |
| 02407965 | TEVA-DEFERASIROX | TEVA CANADA LIMITED | Tablet For Suspension | Oral | DEFERASIROX 250 MG | Cancelled Post Market | |
| 02531291 | TEVA-DEFERASIROX (TYPE J) | TEVA CANADA LIMITED | Tablet | Oral | DEFERASIROX 90 MG | Cancelled Pre Market | |
| 02531313 | TEVA-DEFERASIROX (TYPE J) | TEVA CANADA LIMITED | Tablet | Oral | DEFERASIROX 360 MG | Cancelled Pre Market | |
| 02531305 | TEVA-DEFERASIROX (TYPE J) | TEVA CANADA LIMITED | Tablet | Oral | DEFERASIROX 180 MG | Cancelled Pre Market |
Browse other molecules: